Olympus Biotech Corporation clinical trials
A subsidiary of Olympus Corporation
The registry lists 7 studies whose lead sponsor is Olympus Biotech Corporation. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 5, 2014.
Registry sponsor names on this page
- Olympus Biotech Corporation7 studies
Something wrong with this grouping? Tell us on the Olympus Corporation page.
Studies
Recruiting first, then most recently updated. Showing 7 of 7. All Olympus Corporation studies →
- The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North StudyCompletedNCT01217476Phase 3
Sponsor listed in the registry: Olympus Biotech Corporation
- The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South StudyCompletedNCT01217463Phase 3
Sponsor listed in the registry: Olympus Biotech Corporation
- A Pilot Study to Evaluate an Osteogenic Protein 1 (OP-1) Putty Spinal System and an Autograft Spinal SystemCompletedNCT00678171Not applicable
Sponsor listed in the registry: Olympus Biotech Corporation
- OP-1 Putty for Posterolateral FusionsCompletedNCT00677950Not applicable
Sponsor listed in the registry: Olympus Biotech Corporation
- A Prospective Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral FusionsCompletedNCT00679107Not applicable
Sponsor listed in the registry: Olympus Biotech Corporation
- OP Device vs. Bone Autograft for the Treatment of Tibial NonunionsCompletedNCT00679328Not applicable
Sponsor listed in the registry: Olympus Biotech Corporation
- Study of OP-1 Putty in Uninstrumented Posterolateral FusionsCompletedNCT00678353
Sponsor listed in the registry: Olympus Biotech Corporation